Feasibility and utility of a panel testing for 114 cancer‐associated genes in a clinical setting: A hospital‐based study
Kuniko Sunami(Tokyo National Hospital), Takashi Kohno(Gunma University), Hiroki Kakishima(Tokyo National Hospital), Chigusa Morizane(Tokyo National Hospital), Akihiko Yoshida(Tokyo National Hospital), Noriko Motoi(Tokyo National Hospital), Aoi Sukeda(Tokyo National Hospital), Mayuko Kitami(Tokyo National Hospital), Hitoshi Ichikawa(National Cancer Research Institute), Akihiko Shimomura(Tokyo National Hospital), Kan Yonemori(National Cancer Centre Japan), Mamoru Kato(National Cancer Research Institute), Noriko Tanabe, Noboru Yamamoto(Tokyo National Hospital), Kaishi Satomi(Tokyo National Hospital), Hirokazu Taniguchi(Memorial Sloan Kettering Cancer Center), Atsushi Ochiai(Tokyo University of Science), Takafumi Koyama(Tokyo National Hospital), Kokichi Sugano(Tochigi Cancer Center), Toshio Shimizu(Wakayama Medical University), Akiko Miyagi Maeshima(Tokyo National Hospital), Nobuyoshi Hiraoka(National Cancer Center), Hiroshi Yoshida(Tokyo National Hospital), Eisaku Furukawa(National Cancer Centre Japan), Teruhiko Yoshida, Satoru Iwasa(Tokyo National Hospital), Kenji Tamura(Unknown), Hiromichi Matsushita(Tokyo National Hospital), Taiki Hashimoto(Tokyo National Hospital), Yasuhiro Fujiwara(Yokohama City University), Ken Kato(National Cancer Center Hospital East), Daichi Narushima(National Cancer Centre Japan), Reiko Watanabe(Tokyo National Hospital), Yutaka Fujiwara(National Cancer Centre Japan), Takashi Kubo(National Cancer Center), Masayuki Yoshida(Life Science Institute), Chitose Ogawa(Tokyo National Hospital), Taisuke Mori(National Cancer Centre Japan), Momoko Nagai(National Cancer Centre Japan), Shigeki Sekine(Keio University)
Cited by 375
Related Papers
Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
|Journal of Clinical Oncology|2010|1.6k
Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer
|Journal of Clinical Oncology|2020|1.2k
Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments
|Cancer Cell|2022|828
Trans-ancestry mutational landscape of hepatocellular carcinoma genomes
|Nature Genetics|2014|780
E-CELL: software environment for whole-cell simulation.
|Bioinformatics|1999|765